In a new study, a research team led by Dr. Tracey Rouault in the US National Institute of Child Health and Human Development (NICHD) has found new ways to target an enzyme produced by SARS-CoV-2 called RNA-dependent RNA polymerase (RdRp).

Study: Orally administered drug 'TEMPOL' can inhibit COVID-19's replication

drug-to-block-covid-19

Drug To Block Covid 19, News on Drug To Block Covid 19, stories on Drug To Block Covid 19, articles on Drug To Block Covid 19, Drug To Block Covid 19 stories at Wion, Drug To Block Covid 19 news, Drug To Block Covid 19 latest news

drug to-block-covid-19

Study: Orally administered drug 'TEMPOL' can inhibit COVID-19's replication